论文部分内容阅读
脑梗死为临床常见的脑血管疾病。超早期大剂量尿激酶溶栓治疗是挽救病人生命的关键。然而，许多患者因为种种原因错过了最佳溶栓时机，因此我们采用海王降纤酶治疗此类脑梗死患者，取得了一定疗效。现报告如下。1临床资料全部为住院患者，其中男患18例，女患12例。年龄在38－68
Cerebral infarction is a common clinical cerebrovascular disease. Ultra-early high-dose urokinase thrombolytic therapy is the key to saving the lives of patients. However, many patients missed the optimal timing of thrombolysis for a variety of reasons. Therefore, we have achieved some results using Nepali defibrase in patients with such cerebral infarction. The report is as follows. 1 Clinical data All inpatients, including 18 males and 12 females. Age 38-68